dehydroepiandrosterone sulfate has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jurišić, Z; Lalovac, M; Martinović Kaliterna, D; Perković, D; Radić, M | 1 |
| Lang, B; Lock, G; Schölmerich, J; Straub, RH; Zeuner, M | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Sclerosis, Systemic
| Article | Year |
|---|---|
Androgens in post-menopausal patients with systemic sclerosis.
Topics: Aged; Androstenedione; Antibodies, Antinuclear; Case-Control Studies; Dehydroepiandrosterone Sulfate; DNA Topoisomerases, Type I; Estradiol; Female; Humans; Middle Aged; Nuclear Proteins; Postmenopause; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; Testosterone | 2015 |
High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis.
Topics: Adult; Aged; Cytokines; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Prolactin; Receptors, Interleukin-2; Scleroderma, Systemic; Severity of Illness Index; Solubility; Vascular Cell Adhesion Molecule-1 | 1997 |